However, the underlying mechanism remains elusive and it is unclear about the detailed roles of AMPK in the 6-gingerol-induced treatment of NAFLD, and whether and how LKB1 is involved in the activation of AMPK. Here, STK11 is linked to metabolic dysfunction-associated steatotic liver disease.